"It’s been shown that THC and CBD, when combating the myriad of symptoms and disease states, have a synergistic relationship," explains Steve Looi, Director of Origination at White Sheep Corp., a Toronto-based cannabis commercial operator and strategic investor with holdings in Canada and the US. "The compounds are more effective in each other’s presence than they would be if taken alone."
Given the degree to which marijuana and cannabinoid derivative use has been stigmatized in the past, their Schedule I classification as illegal substances, and lack of FDA approval, valid medical research on the effects of CBD isn’t as plentiful as it should be. Much of the anecdotal evidence, however, suggests that CBD’s neuro- protective, analgesic, and anti-inflammatory effects with regard to topical applications are promising.2
Given the results of this study, it would seem to confirm that full-spectrum extract is preferable over CBD isolate for most CBD users, but CBD isolate is still frequently used and believed by some to be more effective than full-plant extract. This belief is led by the idea that CBD is the only medically sought after cannabinoid in the cannabis plant, aside from THC. Many CBD isolate users are under the impression that by consuming only the CBD cannabinoid and no terpenes or any other "unnecessary" components of the plant, they are getting a more powerful or effective dose of CBD. When vaping a CBD extract, which as stated previously, is considered to be the most efficient and quick-acting method of administering CBD, isolate users may feel that they are taking the most efficient route to CBD consumption. While this method might be efficient, the lack of entourage effect means the benefits are reduced when compared to full-spectrum CBD consumption.
In the United States, the CBD drug Epidiolex has been approved by the Food and Drug Administration for treatment of two epilepsy disorders. The U.S. Drug Enforcement Administration has assigned Epidiolex a Schedule V classification while non-Epidiolex CBD remains a Schedule I drug prohibited for any use. CBD is not scheduled under any United Nations drug control treaties, and in 2018 the World Health Organization recommended that it remain unscheduled.
Return Policy: Once order has been received and you are not satisfied with the product within 30 days of purchase you may return for full refund. Any manufacturer defects or issues on the part of the manufacturer, you may return for a replacement or refund within 30 days of purchase. Pricing and specials are subject to change. Please reach out to your Rep or Sales Manager with any questions regarding the product. Please be aware that the products may contain essential oils and infused herbs, therefore if you have any allergies to such please do not use.